Structure Therapeutics GPCR
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.01M (11 inflow days, 9 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 50.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 8.53% to 8.31% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +1,474,365 | 13.0% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +542,217 | 0.8% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +232,677 | 0.3% |
| abrdn plc | Mutual Fund | 2026/Q3 | +218,869 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +194,797 | 1.0% |
| Impresa Management LLC | VC/PE Fund | 2026/Q3 | +69,807 | 0.5% |
| RTW Investments, LP | Hedge Fund | 2026/Q3 | +1,607,507 | 2.3% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +733,997 | 3.1% |
| Morgan Stanley | Public Company | 2026/Q3 | +498,980 | 3.8% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +460,224 | 10.6% |
| Norges Bank Investment Management | Sovereign Wealth Fund | 2026/Q3 | +426,977 | 0.6% |
| Bank of America Corporation | Public Company | 2026/Q3 | +336,747 | 0.7% |
| Davern Capital Partners, LP | Hedge Fund | 2026/Q3 | +319,598 | 0.6% |
| Deerfield Management Company, L.P. | Hedge Fund | 2026/Q3 | +318,007 | 1.5% |
| HongShan Capital Advisors Limited | VC/PE Fund | 2026/Q3 | +254,750 | 0.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 20 Sep 2026 | Blai Coll | Chief Medical Officer | Other Disposition | -4,008 | – | 15,098 |
| 20 Sep 2026 | Blai Coll | Chief Medical Officer | Other Derivative Acquisition | +4,008 | – | 5,165 |
| 20 Sep 2026 | Blai Coll | Chief Medical Officer | Open Market Derivative Dispositi | -4,008 | – | 1,157 |
| 17 Sep 2026 | Blai Coll | Chief Medical Officer | Sale to Issuer | -3,542 | $35.01 | 15,098 |
| 31 Aug 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Derivative Exercise and Sale | -17,817 | – | 53,578 |
| 31 Aug 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Derivative Exercise and Sale | -5,939 | $47.83 | – |
| 17 Aug 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Derivative Exercise and Sale | -11,817 | – | 53,578 |
| 17 Aug 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Derivative Exercise and Sale | -3,939 | $55.05 | – |
| 5 Aug 2026 | John Berrios | Other Acquisition | +140,766 | – | 140,766 | |
| 5 Aug 2026 | John Berrios | Other Derivative Acquisition | +174,612 | $17.54 | 174,612 | |
| 3 Aug 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Derivative Exercise and Sale | -11,817 | – | 53,578 |
| 3 Aug 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Derivative Exercise and Sale | -3,939 | $50.03 | – |
| 13 Jul 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Other Acquisition | +7,878 | – | – |
| 13 Jul 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Open Market Disposition | -7,878 | $51.71 | – |
| 13 Jul 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Derivative Exercise and Sale | -23,634 | – | 53,578 |
| 13 Jul 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Other Derivative Acquisition | +7,878 | – | 7,878 |
| 13 Jul 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Open Market Derivative Dispositi | -7,878 | – | – |
| 24 Jun 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Other Acquisition | +7,878 | – | – |
| 24 Jun 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Open Market Disposition | -7,878 | $49.08 | – |
| 24 Jun 2026 | Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | Derivative Exercise and Sale | -23,634 | – | 53,578 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 5,927,622 | 8.3% | 6.5 |
| 15 Oct 2026 | 7,147,328 | 10.0% | 4.8 |
| 30 Sep 2026 | 7,540,480 | 10.6% | 5.2 |
| 15 Sep 2026 | 6,605,011 | 9.3% | 5.2 |
| 31 Aug 2026 | 5,854,907 | 8.2% | 7.9 |
| 14 Aug 2026 | 6,079,970 | 8.5% | 10.4 |
No comments yet — be the first to weigh in on GPCR.
Sign in to join the discussion.